Skip navigation
  •  Home
  • UDC 
    • Getting started
    • RUC Policies
    • FAQ
    • FAQ on Copyright
    • More information at INFOguias UDC
  • Browse 
    • Communities
    • Browse by:
    • Issue Date
    • Author
    • Title
    • Subject
  • Help
    • español
    • Gallegan
    • English
  • Login
  •  English 
    • Español
    • Galego
    • English
  
View Item 
  •   DSpace Home
  • Facultade de Ciencias da Saúde
  • Investigación (FCS)
  • View Item
  •   DSpace Home
  • Facultade de Ciencias da Saúde
  • Investigación (FCS)
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Generation of a human control iPS cell line (ESi080‐A) from a donor with no rheumatic diseases

Thumbnail
View/Open
DiazPrado_2020_Generation_human.pdf (1.496Mb)
DiazPrado_2020_Generation_human_Supplementary_material.pdf (307.1Kb)
DiazPrado_2020_Descripcion_Datasets.pdf (775.5Kb)
DiazPrado_2020_Datasets.zip (2.545Mb)
Use this link to cite
http://hdl.handle.net/2183/25411
Creative Commons Attribution 4.0 International Licence (CC-BY 4.0)
Except where otherwise noted, this item's license is described as Creative Commons Attribution 4.0 International Licence (CC-BY 4.0)
Collections
  • Investigación (FCS) [1293]
Metadata
Show full item record
Title
Generation of a human control iPS cell line (ESi080‐A) from a donor with no rheumatic diseases
Author(s)
Castro Viñuelas, Rocío
Sanjurjo-Rodríguez, Clara
Piñeiro-Ramil, María
Rodríguez-Fernández, Silvia
Fuentes Boquete, Isaac Manuel
Blanco García, Francisco J
Díaz-Prado, Silvia
Date
2020-03
Citation
Castro-Viñuelas R, Sanjurjo-Rodríguez C, Piñeiro-Ramil M, Rodríguez-Fernández S, Fuentes-Boquete IM, Blanco FJ, Díaz-Prado SM. Generation of a human control iPS cell line (ESi080-A) from a donor with no rheumatic diseases. Stem Cell Res. 2020 Mar;43:101683.
Abstract
[Abstract] Here, we report the establishment of the human iPS cell line N1-FiPS4F#7 generated from skin cells of a patient with no rheumatic diseases, thus obtaining an appropriate control iPS cell line for researchers working in the field of rheumatic diseases. The reprogramming factors Oct4, Sox2, Klf4 and c-Myc were introduced using a non-integrating reprogramming strategy involving Sendai Virus.
Keywords
Human iPS
Reprogramming
Sendai virus
Pluripotency
Cell line
Embryoid body
 
Editor version
https://doi.org/10.1016/j.scr.2019.101683
Rights
Creative Commons Attribution 4.0 International Licence (CC-BY 4.0)
ISSN
1873-5061
1876-7753
 

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsResearch GroupAcademic DegreeThis CollectionBy Issue DateAuthorsTitlesSubjectsResearch GroupAcademic Degree

My Account

LoginRegister

Statistics

View Usage Statistics
Sherpa
OpenArchives
OAIster
Scholar Google
UNIVERSIDADE DA CORUÑA. Servizo de Biblioteca.    DSpace Software Copyright © 2002-2013 Duraspace - Send Feedback